Pimple Killer Genomma Advances Most Since 2009 After EarningsBy and
Stock climbs after sales, profit exceed analysts' forecasts
Company reports stronger-than-expected revenue in U.S., Mexico
Genomma Lab Internacional SAB, the Mexican seller of remedies for acne and baldness, jumped the most since May 2009 after earnings beat analysts’ estimates.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.